Barbara Sennino

Barbara Sennino is an accomplished professional in the field of immunotherapy, currently serving as Vice President at Turnstone Biologics since April 2022. Prior to this role, Barbara held various significant positions at PACT Pharma from June 2017 to April 2022, including Senior Director and Director of Tumor Immunology. Barbara's earlier experience includes leadership roles at Five Prime Therapeutics, Inc. and Bavarian Nordic, as well as a longstanding tenure at UCSF, where Barbara served as both staff scientist and postdoctoral fellow. With a strong background in tumor immunology and pharmacology, Barbara has demonstrated expertise in advancing research and development in the biotechnology sector.